Publications by authors named "Pierre Rivet"

Claim this Profile
I
Impact of next-generation sequencing on routine clinical practice and patient inclusion in molecularly targeted clinical trials: a retrospective cohort analysis.
Mathieu Faigner, Lucie Karayan-Tapon, Ulrich Cortes, Birama Ndiaye, Marine Martel, Pierre Rivet

Clin Transl Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemistry, Molecular Biology, and Clinical Scoring for the Detection of Muir-Torre Syndrome in Cutaneous Sebaceous Tumors: Which Strategy?
Hélinie Sinson, Lucie Karayan-Tapon, Julie Godet, Pierre Rivet, Camille Alleyrat

Dermatology· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MEOX2 Transcription Factor Is Involved in Survival and Adhesion of Glioma Stem-like Cells.
Gaëlle Tachon, Konstantin Masliantsev, Pierre Rivet, Amandine Desette, Serge Milin

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of MEOX2 in gliomas.
Gaelle Tachon, Konstantin Masliantsev, Pierre Rivet, Christos Petropoulos, Julie Godet

Mod Pathol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51.
Gaelle Tachon, Ulrich Cortes, Pierre-Olivier Guichet, Pierre Rivet, Anais Balbous

Int J Mol Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients.
Véronique Quillien, Audrey Lavenu, François Ducray, David Meyronet, Olivier Chinot, Pierre Rivet

Cancer Biomark· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crizotinib targets in glioblastoma stem cells.
Audelaure Junca, Claire Villalva, Gaëlle Tachon, Pierre Rivet, Ulrich Cortes

Cancer Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial.
Véronique Quillien, Audrey Lavenu, François Ducray, Marie-Odile Joly, Olivier Chinot, Pierre Rivet

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.
Anaïs Balbous, Ulrich Cortes, Karline Guilloteau, Pierre Rivet, Baptiste Pinel

BMC Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions.
Claire Villalva, Ulrich Cortes, Michel Wager, Jean-Marc Tourani, Pierre Rivet

Int J Mol Sci· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma.
Anaïs Balbous, Brigitte Renoux, Ulrich Cortes, Serge Milin, Karline Guilloteau, Pierre Rivet

Mol Cancer Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Suspected malignant cancer of the pancreas associated with pseudo-invasive duodenal hamartomas in a patient with Peutz-Jeghers syndrome].
Pierre-Emmanuel Rautou, Pascal Hammel, Anne Couvelard, Pierre Rivet, Alain Aubert

Gastroenterol Clin Biol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis